로딩 중…
지수 로딩 중…
ILYANG PHARMACEUTICAL CO.,LTD
007570· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩8,460+0.36%
2026-08-04
Financials
Valuation Metrics
ILYANG PHARMACEUTICAL CO.,LTD's Market Cap is ₩1642B. At end of 2025 it was ₩2844B. Ranked #933 of 2,436 in KR market (top 38%), #487 of 787 on KOSPI (top 62%), #106 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 45%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 164.19B KRW | KR#933/2,436 Sec#106/234 |
| Revenue | 275.51B KRW | KR#849/2,436 Sec#40/234 |
| Net Income | 20.32B KRW | KR#641/2,436 Sec#44/234 |
| Total Assets | 465.54B KRW | KR#778/2,436 Sec#47/234 |
| Net Assets | 257.53B KRW | KR#779/2,436 Sec#52/234 |
| Employees | 668 | KR#373/2,436 Sec#32/234 |
| Value | ||
| P/E | 8.08x | KR#574/2,436 Sec#27/234 |
| P/B | 0.64x | KR#1,056/2,436 Sec#52/234 |
| PEG | 0.02x | KR#148/2,436 Sec#4/234 |
| P/S | 0.60x | KR#1,056/2,436 Sec#48/234 |
| FCF Yield | 3.85% | KR#946/2,436 Sec#55/234 |
| Profitability | ||
| ROE | 7.89% | KR#703/2,436 Sec#45/234 |
| ROA | 4.36% | KR#730/2,436 Sec#60/234 |
| Op. Margin | -2.10% | KR#1,747/2,436 Sec#120/234 |
| Revenue Growth | 4.99% | KR#1,163/2,436 Sec#108/234 |
| Earnings Growth | 349.11% | KR#155/2,436 Sec#10/234 |
| Financial Health | ||
| Debt Ratio | 180.77% | KR#1,540/2,436 Sec#174/234 |
| Total Debt | 194.77B KRW | KR#498/2,436 Sec#27/234 |
| FCF | 6.32B KRW | KR#838/2,436 Sec#55/234 |
| Cash | 34.79B KRW | KR#924/2,436 Sec#62/234 |
| Current Ratio | 0.93x | KR#1,900/2,436 Sec#190/234 |
| Dividend | ||
| Div. Yield | 1.84% | KR#926/2,436 Sec#48/234 |
| Div. Growth | 3.33% | KR#654/2,436 Sec#35/234 |
| Performance | ||
| 1Y Return | -41.56% | KR#1,878/2,436 Sec#167/234 |
| 1M Return | 1.56% | KR#726/2,436 Sec#63/234 |
| From 52W High | -47.91% | KR#1,096/2,436 Sec#93/234 |
| 1Y MDD | -56.76% | KR#1,237/2,436 Sec#100/234 |
| Trading | ||
| Volume | 15,300 shares | KR#1,977/2,436 Sec#197/234 |
| Foreign Own. | 6.15% | KR#697/2,436 Sec#67/234 |
| Per Share | ||
| EPS | 1,032 KRW | KR#611/2,436 Sec#43/234 |
| BPS | 13,825 KRW | KR#711/2,436 Sec#50/234 |
Company Info
동사는 1946년 설립, 1971년 법인 전환 후 2009년 일양바이오팜(주) 설립과 함께 중국 시장 진출을 위해 일양약품(길림)유한공사를 신설하였음. 제14호 신약 놀텍, 제18호 신약 슈펙트, 계절독감백신 등의 전문의약품과 원비디 등 일반의약품, 원료의약품, 건강보조식품을 제조판매하고 있음. 시장점유율 증대를 위한 R&D 투자와 글로벌 혁신의약품 개발을 최우선으로 하고 있음. 일양약품는 1946년에 설립되었으며 경기도 용인시에 본사를 두고 있습니다.